The physical and biological state of the Marek's disease virus (MDV) genome in avian leukosis virus (ALV)-transformed cells is characterized using cell lines established from ALV tumours co-infected with the SB-1 strain of MDV. The MDV genome within the ALVtransformed cells was found to be methylated at 5' CpG 3' dinucleotides. Less than 2% of the tumour cells expressed MDV antigen and only one virus plaque that was characteristic of an MDV infection was noted when tumour cells were cocultured with fibroblasts permissive for a productive MDV infection. However, when methylation of the MDV genome was prevented by culturing the tumour cell lines in the presence of 5-azacytidine, both MDV antigen expression and viral replication increased. Based on these results, it appears that MDV resides within the ALV-transformed cells in a latent state and that MDV latency might be influenced, to some extent, by methylation of the MDV genome.
Introduction
Avian leukosis virus (ALV) and Marek's disease herpesvirus (MDV) are significant pathogens of poultry. It is known that infection with pathogenic strains of either of these viruses results in the formation of malignant lymphomas (Payne, 1982; Purchase, 1986) . However, ALV and MDV malignantly transform different cell types of the lymphoid system. ALV transforms B cells, whereas MDV infection has been shown to cause the transformation of only T lymphocytes. However, it has been observed that chickens infected with ALV and a non-oncogenic strain of MDV (SB-1), used routinely as a vaccine (Schat & Calnek, 1978) , experienced a higher incidence of lymphoid leukosis than those birds exposed to ALV alone (Bacon et at., 1989) . The mechanism of this enhancement is unknown. Our previous work showed that MDV was present in greater than 90 % of the B cell turnouts removed from birds receiving both viruses (Fynan et al., 1992) . These findings suggest that ALV and MDV may cooperate in the development of B cell tumours. Our previous studies did not, however, determine whether the entire infectious MDV genome was present in the ALV-transformed turnout cells. Moreover, the biological status of the MDV genome was not characterized.
In view of the effect of MDV infection upon enhancement of B lymphoid tumour development, we sought to examine the state of expression of the MDV genome in ALV-transformed cells. For convenience, cell lines were established from B cell lymphomas isolated from chickens infected with both ALV and MDV strain SB-1. In a separate report, we have shown that the cell lines resemble the primary tumours in that the ALV provirus is integrated at the same location in the myc proto-oncogene in the cell line and the tumour from which it was derived (Fynan et at., 1992) . In this report, we examine the expression of the MDV strain SB-1 using two of the ALV-transformed cell lines, and show, for the first time, that the MDV genome can persist in ALVtransformed B cells in a non-productive state that is capable of responding to exogenous stimuli by reactivating to produce infectious virus. The relevance of the presence of infectious MDV within an ALV tumour cell to MDV and ALV pathogenesis is also considered.
Isolation and separation of total cellular DNA. DNA was isolated by standard methods (Ausubel et al., 1987) . Briefly, cells were washed twice in PBS and then resuspended in 100mM-NaCI, 10mM-Tris-HC1 pH 8-0, 25 mM-EDTA, 0.5 % SDS. Proteinase K was then added to a final concentration of 250 pg/ml. Samples were incubated at 50 °C overnight, phenol-chloroform-extracted and precipitated with 0.1 volume 2.5 M-sodium acetate and 2.5 volumes of ethanol.
Tumour DNA (5 gg) was digested with restriction enzymes and separated on an 0.8% agarose gel. Samples were transferred to nitrocellulose (Schleicher & Schuell) and hybridized with a2P-labelIed DNA probes as described (Sambrook et al., 1989) . Radioactive probe was removed from the membranes according to the manufacturer's instructions. Membranes were placed in a boiling solution of 0.1 x SSC [(20 x SSC is 3 M-NaC1, 0.3 M-sodium citrate, pH 7.0)/0.1% SDS] and rocked until cool. This procedure was repeated until no radioactive counts were detected. Dot blot analysis. Cells (5 x 10 z to 1 x 106 cells/well) were applied to nylon membranes (Schleicher & Schuell) and dried. Cells were lysed, denatured and neutralized in situ by wetting the membrane in 10% SDS for 3 rain, denaturation solution (0"5 M-NaOH, 1.5 M-NaCl) for 5 rain, neutralization solution (1.5 M-NaC1, 0.5 M-Tris HCI pH 8.0) for 5 min, 2 x SSPE (20 x is 3 M-NaC1, 0.2 M-sodium phosphate, 0.02 M-EDTA, pH 7"4) for 5 min and dried. Prehybridization and hybridization were performed as described (Sambrook et al., 1989) . The radioactive DNA probe was removed from the membrane by the method described by the manufacturer. Nytran membranes were washed in 50% deioinized formamide/6 x SSPE at 68 °C for 30 min. Washes were repeated until blots were free of radioactive counts.
Fluorescent antibody staining. Cell-associated MDV antigen was detected by indirect immunofluorescence analysis. Fibroblasts grown on coverslips or cytocentrifuge preparations of lymphoid cell lines were fixed in 2% acetic acid in ethanol at -10°C for 20min. After rehydration, the cells were incubated with mouse monoclonal antibody Y5 which is specific for serotype II MDV antigens (Lee et al., 1983) . Cell-bound antibody was detected with fluorescein isothiocyanatelabelled goat anti-mouse immunoglobulin antibody using a Leitz epiftuorescence microscope.
Results

Marek's disease virus DNA is present in ALV tumourderived cell lines
We have previously shown that most ALV-transformed tumours isolated from MDV (strain SB-1)-vaccinated chickens contain MDV DNA (Fynan et al., 1992) . To analyse the persistence of the MDV genome in ALVtransformed cells, cell lines were established from a number of tumours. We have previously shown that ALV-transformed B cell lines contain MDV DNA sequences using hybridization with an MDV serotype 2-specific probe (Fynan et al., 1992) . The DNA fragment used as a probe in these experiments was derived from the short repeat region of the MDV genome (Fig. 1 a) .
The presence of MDV DNA in two ALV-transformed cell lines, 229 and 740, is shown in Fig. 2(a) . Hybridization of the MDV strain SB-l-specific probe, pA5, to DNA digested with EcoRI and BamHI isolated from cells productively infected with MDV strain SB-1 results in the detection of discrete bands of 3.2, 2.9, 1.1, 1.0 and 0.9 kb. The 1.1, 1.0 and 0"9 kb bands occur at twice the molar amount of the 3.2 and 2.9 kb fragments because they are derived from the internal repeats and occur at least twice per genome (see Fig. 1 (Fig.  2b) .
A L V tumour-derived cells mainta&ed in culture produce very low to undetectable levels of M D V
Since the ALV-transformed cell lines contain MDV DNA, the biological activity of M D V within the ALV tumour-derived cell lines was studied. To determine whether infectious MDV was produced, tumour cell lines were cocultured with chick embryo fibroblasts which are permissive for an MDV productive infection. Even after 7 days of culture (typical for an MDV productive infection), no plaques characteristic of an MDV infection were observed in those cocultivations of cell line 740. Only one plaque was detected following culture of cell line 229 with chick embryo fibroblasts. Analysis of MDV viral antigen production by immunofluorescent staining revealed that only 1% of the ceils expressed an M D V structural protein ( Table 1 ). Note that the low level to undetectable amount of M D V antigen and virus production by these cells was not due to heterogeneity of tumour cells within the culture with respect to the presence of MDV genomes. That is, there is not a predominance of turnout cells that do not contain the M D V genome. We found that all of 20 clonal isolates of cell line 229 continue to harbour the M D V genome (data not shown). Therefore, the M D V genome appears to be maintained in most or all of the cells in the population. Thus, although M D V D N A was present and persisted in these tumour-derived cell lines, little evidence of viral replication was observed. Taken together, these results suggested that MDV persisted within the ALVtransformed cells in a latent or quiescent state.
M D V DNA is highly methylated in A L V tumourderived cell lines but not in M D V-infected fibroblasts
Since latent herpesvirus genomes have been shown to possess methylation patterns distinct from genomes isolated from productively infected cells (Desrosiers et al., 1979; Kanamori et al., 1987; Youssoufian et al., 1982) , we examined whether the MDV DNA in these tumour cell lines displayed this characteristic of latent viral genomes. Therefore, D N A was isolated and digested with the restriction enzymes MspI and HpaII (Fig. 3) . Both enzymes cleave at the site 5' C C G G 3', but cutting by HpaII does not occur when the internal cytosine residue is methylated (Waalwijk & Flavell, 1978) . MspI digestion of D N A isolated from fibroblasts productively infected with MDV strain SB-1 results in D N A fragments of equal to and less than 0.6 kb. This indicates that there are many MspI sites within the region probed, as expected for an enzyme that recognizes only a four base pair sequence (Fig. 3) . The digestion patterns of DNA from MDV strain SB-l-infected fibroblasts cleaved with MspI or HpaII are similar, indicating that viral D N A from productively infected cells possesses little methylation in the region probed (Fig. 3, lanes 1, 2) .
The These results indicate that the physical state of the MDV genome in the tumour cells is different from that present during an active infection and that the MDV genome is heterogeneous with respect to methylation. Furthermore, we have shown that the MDV genome in these ALV tumour cell lines is likely to be modified by methylation of 5' CpG 3' dinucleotides, a characteristic of inactive herpesvirus genomes (Desrosiers et al., 1979; Kanamori et al., 1987; Minarovits et al., 1991; Youssoufian et al., 1982) .
Effect of 5-azacytidine on MD V DNA synthesis
Having shown that the methylation pattern of MDV DNA isolated from the tumour cell lines differed from that of productively infected cells, we examined whether a change in methylation would affect the biological state of MDV in these tumour cell lines. Therefore, to determine whether a decrease in the level of methylation would lead to an increase in viral gene expression, the established M D V -A L V tumour cell lines were treated with an inhibitor of methylation, 5-azacytidine (Taylor et al., 1984) . ALV tumour cell lines 229 and 740 were cultured for 3 days in the presence of 5-azacytidine. D N A was isolated from the cells and digested with MspI or HpaII as in Fig. 3 . The inability of HpaII to digest cell line D N A isolated from cultures that had not been exposed to 5-azacytidine indicated that the MDV D N A in the ALV tumour-derived cell lines was methylated at cytosine residues (Fig. 3, lanes 2, 4, 6 ). However, cell line D N A isolated from cultures that had been treated with 5-azacytidine showed a restriction enzyme pattern similar to that of D N A isolated from chick embryo fibroblasts productively infected with MDV (Fig. 4, lanes 2, 4, 6 ). These results suggested that the MDV genome in the ALV tumour cell lines was unmethylated at cytosine residues following exposure to 5-azacytidine.
Having shown that culture in the presence of 5-azacytidine inhibited cytosine methylation of MDV DNA, the effect of hypomethylation on D N A synthesis was examined. To quantify the degree of amplification of MDV D N A in 5-azacytidine-treated turnout cell lines, equal numbers of cells, 5-azacytidine-treated or untreated, were applied to nylon membranes by use of a 'dot blotter' (see Methods) and probed for MDV. of the host cell fl-actin gene (Fig. 5 b) . We conclude that undermethylation of the viral DNA is associated with a dramatic increase in MDV genome copy number per cell. 
Expression of M D V in A L V tumour-derived cell lines following treatment with 5-azacytidine
Since the level of MDV DNA synthesis was increased by exposure of the tumour cell lines to 5-azacytidine, experiments were performed to determine whether this treatment would disrupt the quiescent state and lead to the expression of MDV antigens. The turnout cell lines were cultured in the presence of 5-azacytidine and examined at 72 h for MDV antigen expression by immunofluorescence analysis. MDV strain SB-1 protein expression was detected using an MDV serotype 2-specific monoclonal antibody to an MDV structural protein (Lee et al., 1983) . After culture of the tumour cell lines in medium containing 5-azacytidine for 72 h, an increase in the number of cells expressing MDV antigen was observed. The level of antigen expression in cell lines 229 and 740 increased from 0.3 % and 1.3 % of the untreated cells to 27 % and 21% of cells of lines 229 and 740, respectively (Table 1) . As an example, Fig. 6(a) shows phase contrast microscopy of tumour cells of line 740 following treatment for 72 h with 5-azacytidine.
Immunofluorescent staining for an MDV antigen shows cells expressing MDV protein (Fig. 6b) . As shown in Fig. 6 , a clear distinction could be made between MDV antigen-positive and -negative cells. These experiments show that MDV protein expression is enhanced following exposure to 5-azacytidine, at least for proteins detected by the Y5 antibody.
The increase in MDV DNA synthesis and protein expression following exposure to the methylation inhibitor, 5-azacytidine, suggested that the ALV B cell tumour lines might be capable of producing infectious MDV. Therefore, these tumour cell lines were cocultured with chicken embryo fibroblasts, which are permissive for MDV infection, and observed for c.p.e, typical of MDV infection. Since treatment with 5-azacytidine was shown to increase the level of MDV DNA synthesis and antigen detection, untreated tumour cell lines as well as those exposed to 5-azacytidine for 72 h were cultured with chick embryo fibroblasts. Tumour cell fines were cultured with secondary cultures of chicken embryo fibroblasts at a ratio of one tumour cell for every 100 chick embryo fibroblasts. The ALV turnout cells were washed off after 24 h of culture and the fibroblast cultures were allowed to continue. After 4 days of culture, plaques typical of an MDV strain SB-1 infection were observed in wells that had received cell lines 740 or 229 pretreated with 5-azacytidine (Table 1) . Only one plaque was noted in a well containing cell line 229 which had not been exposed to azacytidine. Fig. 6 (e) shows a representative MDV-type plaque in chick embryo fibroblasts cultured with cell line 740. Immunofluorescence analysis of this culture (d) shows that the MDVproducing cells are chick embryo fibroblasts, based on their distinctive spindle-shaped morphology, and not residual B cells. Therefore, infectious virions had been released from the original 5-azacytidine-treated B cells and passed on to permissive chick embryo fibroblasts.
The presence of fibroblasts infected with MDV strain SB-1 demonstrates that these cell lines are capable of producing infectious MDV virions and is evidence that an intact, non-defective MDV genome is present in these cell lines. Given these findings, we conclude that MDV strain SB-1 resides for the most part in these ALV tumours, in an inactive or latent state, and can be reactivated by treatment with the cytosine methylation inhibitor, 5-azacytidine.
Discussion
Continuous cell cultures have been established from ALV-transformed B cells derived from chickens that had also been infected with the vaccine strain of MDV, SB-1. In a previous report, we have shown that, unexpectedly, almost all ALV tumours occurring in chickens that had also been infected with the non-oncogenic MDV vaccine strain SB-1 contained MDV DNA (Fynan et al., 1992) . However, the functional potential of the MDV genome in those cells was not studied.
This report describes the functional potential of the MDV genomes contained in two continuous cell cultures of ALV B cell tumours isolated from chickens coinfected with MDV strain SB-1 and ALV (RAV-1). These cell cultures, called 229 and 740, were of B cell origin and contained ALV proviral insertions in the cmyc locus, which is a characteristic of ALV-transformed B cells (Ewert & DeBoer, 1988) . Cell lines 229 and 740 were examined for the presence of SB-1 DNA using a probe specific for the MDV short repeat region (pA5). Based upon this analysis, both lines contained the MDV genome. Preliminary analysis by pulsed field gel electrophoresis showed that the majority of the MDV homologous DNA does not exist in a linear or episomal form but probably is present as a high M,. form, such as concatemers or integrated into the host cell DNA. However, this method of separation does not allow us to distinguish between these high M r physical forms (data not shown). Although little or no infectious MDV or MDV antigens were detected in either cell line kept in maintenance culture, viral DNA synthesis, gene expression and viral plaque formation were observed in cultures incubated with 5-azacytidine. This shows that an infectious MDV genome is present in 229 and 740 cell lines in a quiescent state. Moreover, the MDV genome could be activated by cultivation with a drug that inhibits DNA methylation.
These results are significant because they show that the B cell compartment is capable of harbouring the MDV genome in a stable state. Furthermore, the MDV genome within the transformed B cells is able to be reactivated. Therefore, B cells which have been shown to be a site of productive MDV infection in vivo may also be a reservoir for latent virus.
Our previous work showed the coincidence of MDV in ALV-derived B cell turnouts (Fynan et al., 1992) . Since chickens co-infected with the non-oncogenic MDV strain SB-1 and ALV experience a greater frequency of ALVinduced B cell tumours than those receiving ALV alone, it is tempting to speculate that the reported MDV strain SB-1-mediated enhancement of ALV tumorigenesis is, in part, a consequence of an intracellular effect of MDV upon the ALV genome, or upon the host cell that harbours the two viruses. Alternatively, MDV may be an innocent bystander coincidentally resident in the same cells that are transformed by ALV. More work is needed to distinguish between these possibilities.
In quiescent ALV-transformed cell lines 229 and 740, the region of the MDV genome recognized by the pA5 probe showed resistance to digestion with HpaII but not with MspI. Since these two restriction enzymes both cleave at 5' CCGG 3' sequences, but HpaII is unable to cleave when the internal cytosine is methylated, it is likely that this region of the MDV genome is heavily methylated. The DNA of mammalian cells is modified by methytation at 2 to 7 % of the cytosine residues (Ehrlich & Wang, 1981) . This modification has been associated with a transcriptionally inactive state (Doerfler, 1982) . The pA5 region of the MDV strain SB-1 genome may contain DNA sequences that must be repressed to maintain the virus in a latent state. For example, based upon genomic location and homology compared to other herpesviruses, the pA5 region may contain an origin of replication and a cleavage/packaging site used during productive infection (Carter & Silva, 1990) . This suggests that methylation of this region of the SB-1 genome within the pA5 region may be important in the maintenance of the latent state.
The quiescent genomes of retroviruses, adenoviruses and herpesviruses in their respective latently infected cells have been shown to be heavily methylated at 5' CpG 3' residues (Desrosiers et al., 1979; Groudine et al., 1981; Hoffman et al., 1982; Kanamori et al., 1987; Minarovits et al., 1991) . Moreover, inhibition of 5' CpGY methylation with 5-azacytidine has been associated with the reactivation of such latent genomes (Ben-Sasson & Klein, 1981; Groudine et al., 1981; Hoffman et al., 1982; Niwa & Sugahara, 1981) . Therefore, cultures of cell lines 229 and 740 were incubated with 5-azacytidine and tested for evidence of MDV genome reactivation. Significantly, although the copy number of the host cell gene (actin) remained relatively stable, 5-azacytidine-treated cultures experienced a 20-to 30-fold increase in the copy number of MDV DNA sequences. In addition, a viral late antigen was detectable. Most significantly, unlike untreated cells, cultures incubated with 5-azacytidine released infectious MDV, as assayed in cocultivation experiments.
The pA5 region of the MDV genome isolated from 5-azacytidine-treated 229 and 740 cell cultures was shown to have gained sensitivity to the restriction enzyme HpaII. This shows that this region of the genome had become hypomethylated as a result of 5-azacytidine treatment. Although 5-azacytidine may have many effects upon target cells (Taylor et al., 1984) , we feel it is possible that the reactivation of the latent MDV genomes in 5-azacytidine-treated 229 and 740 cultures was the result of hypomethylation. However, the ALVtransformed cell lines may contain MDV DNA in a physical state such that it is unable to undergo replication in response to treatment with 5-azacytidine.
This report shows, for the first time, the presence of latent MDV in a B cell population. The identity of any host, ALV or MDV genes that regulate the MDV genome in latently infected B cells remains to be determined. Similarly, the pathological significance of infectious MDV in B cells, in general, and ALVtransformed B cells, in particular, is unclear. Both of these aspects require further investigation.
